AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Empagliflozin & Linagliptin in Kenya
7 products registered with PPB — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EMPAGOOD 25 L Tablet | H2025/CTD11584/25330 | ZAIN PHARMA LIMITED | active | 6 Dec 2030 |
| Empazin-L 10mg/5mg Tablet Tablet | H2025/CTD11832/26166 | Pharmatec Pakistan (Pvt.) Ltd | active | 27 Aug 2030 |
| Empazin-L 25mg/5mg Tablet Tablet | H2025/CTD11833/26167 | Pharmatec Pakistan (Pvt.) Ltd | active | 27 Aug 2030 |
| Empiget-LT Tablets 10mg+5mg Film-Coated Tablet | H2022/CTD10803/22171 | GETZ PHARMA (PRIVATE) LIMITED | active | 21 Nov 2028 |
| Empiget-LT Tablets 25mg+5mg Film-Coated Tablet | H2022/CTD10805/22163 | GETZ PHARMA (PRIVATE) LIMITED | active | 21 Nov 2028 |
| Glympa 10/5 Tablet Tablet | H2022/CTD9879/22543 | Square Pharmaceuticals Ltd. | active | 25 Apr 2028 |
| Glympa 25/5 Tablet Tablet | H2022/CTD9880/22544 | Square Pharmaceuticals Ltd. | active | 25 Apr 2028 |
Empagliflozin & Linagliptin — PPB Registration Details
PPB (Kenya) has 7 registered products containing Empagliflozin & Linagliptin, of which 7 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Empagliflozin & Linagliptin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.